MoonLake Therapeutics drew intense retail interest ahead of its New York dermatology summit, with traders expecting clinical and regulatory updates. A recently shared company deck outlining trial readouts and meetings has fueled optimism, with many on Stocktwits seeing a strong catalyst runway extending into 2026.